Life After the FDA Social Media Hearings: Applying the rules today

Click here to view on demand

With the FDA Internet and social media hearings now complete, many Pharma marketers are left trying to answer the question, "what am I supposed to do TODAY?" Formal guidance may not be issued until 2011, yet marketers still have the need to execute digital programs responsibly.

Experts from pharma marketing, digital media and regulatory disciplines will use case studies to examine the key regulatory challenges surrounding online marketing and offer potential solutions and tactics for effectively leveraging this channel within the complex legal environment.

The event will focus on the following core online strategies:

  • Websites
  • Search Marketing
  • Display Advertising
  • Social Media

Moderator
Marc Iskowitz, executive editor, Medical Marketing & Media

Sponsored by Klick Pharma


You must be a registered member of MMM to post a comment.

Pharma continues to struggle with its image. Exhibit A is the public debate around the price of, and access to, new and innovative meds. As countless transformative technologies hit market, has industry done enough to anchor its permission to innovate? To provide a closer look at trends affecting trust over the past year, MM&M presents this e-book, "The 2015 Edelman Trust Barometer." Click here.

Email Newsletters